Radiotherapy: Clinical Trials

639 trials of Radiotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

347 completed, 93 terminated, 55 active not recruiting, 46 recruiting. 639 Phase 1, 245 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 1639Completed 347, Terminated 93, Active not recruiting 55, Recruiting 46, Unknown 46, Withdrawn 35, Not yet recruiting 13, Enrolling by invitation 2, Suspended 2
Phase 2245Completed 123, Terminated 41, Unknown 25, Active not recruiting 19, Recruiting 16, Withdrawn 11, Not yet recruiting 7, Enrolling by invitation 2, Suspended 1

Follow Radiotherapy: new trials by email Literature Review of Radiotherapy trials Research Report on Radiotherapy

Trials (filtered) newest first · largest first

All 639 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
NG101m Adjuvant Therapy in Glioblastoma Patients
Intensity-modulated radiation therapy, Temozolomide, NG101m - Glioblastoma Multiforme
Phase 1 / Phase 2Not yet recruitingNeuGATE Theranostics522027-01-012025-10-21
Testing Safe Doses of Anti-Cancer Medicines, 5-Flurouracil (5-FU) and Tretinoin (ATRA), Added to the Usual Cancer Treatment of Ependymoma
Biospecimen Collection, Echocardiography Test, Fluorouracil - Childhood Posterior Fossa Ependymoma
Phase 1 / Phase 2Not yet recruitingChildren's Oncology Group702026-12-112026-09-30
Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer
Neoadjuvant Chemotherapy, Radiation Therapy, MRI - Breast Cancer, HER2-positive Breast Cancer
Phase 1 / Phase 2Not yet recruitingOhio State University Comprehensive Cancer Center842026-09-152026-06-24
Thermotherapy for Head and Neck Cancer Patients
Thermotherapy, Radiotherapy, Concurrent chemoradiation - Head and Neck Cancer, Oropharyngeal Carcinoma
Phase 1RecruitingErasmus Medical Center302026-09-012026-09-02
A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab
Computed Tomography, Copper Cu 64-DOTA-pembrolizumab, Low Dose Radiation Therapy - Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Brain
Phase 1RecruitingCity of Hope Medical Center62026-09-012026-10-19
Radiation to Treat Joint Damage Caused by Cancer Immunotherapy
Low dose radiation therapy - Arthritis, Arthropathy
Phase 1Not yet recruitingUniversity of Chicago202026-08-262026-03-23
Low-Dose Radiotherapy for Alzheimer's Disease
Low Dose Radiation Therapy - Alzheimer Dementia, Dementia
Phase 1 / Phase 2RecruitingEvan Thomas502026-07-152026-07-09
Integrating Biology for Safe Intensification of Glioblastoma Hypofractionated Treatment on the MR-Linac
MR-Linac System, Radiation Therapy, Temozolomide - High-grade Glioma
Phase 1Not yet recruitingNYU Langone Health202026-06-012026-03-09
Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas
Vancomycin 125mg, Radiation Therapy, CAR-T - Large B Cell Lymphoma, Non Hodgkin Lymphoma (NHL)
Phase 1RecruitingAbramson Cancer Center at Penn Medicine142026-05-292026-07-01
Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma
Biopsy, Biospecimen Collection, Computed Tomography - Soft Tissue Sarcoma
Phase 1WithdrawnRoswell Park Cancer Institute2026-05-152025-08-26
A Study of Ta-NPs Plus Radiotherapy for Locally Recurrent Retroperitoneal Sarcoma
Ta-NPs (2% Tumor Volume), Ta-NPs (5% Tumor Volume), Ta-NPs (10% Tumor Volume) - Locally Recurrent Retroperitoneal Soft Tissue Sarcoma
Phase 1Not yet recruitingWest China Hospital92026-05-012026-05-11
Re-radiotherapy Combined With Chidamide for the Treatment of Recurrent Head and Neck Squamous Cell Carcinoma After Radiotherapy
Chidamide, radiotherapy - Head and Neck Squamous Cell Carcinoma HNSCC
Phase 1RecruitingWest China Hospital62026-04-232026-04-28
Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas
Fludarabine, Cyclophosphamide, B7-H3-CAR T Cells - Sarcoma, Childhood Osteosarcoma
Phase 1RecruitingSt. Jude Children's Research Hospital422026-01-212026-02-09
Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers
Capecitabine, Docetaxel, Fluorouracil - Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8
Phase 1WithdrawnOhio State University Comprehensive Cancer Center2025-12-312025-02-07
A Phase I Study of WTX212A Monotherapy or in Combination With Radiotherapy in Patients With Advanced Solid Tumors
WTX212A injection, radiotherapy - Solid Tumor Cancer, Cancer
Phase 1RecruitingSun Yat-sen University122025-11-252025-12-08
A Two-cohort Study of SHR-A1811 in the Treatment of HER2-positive Breast Cancer With Brain Metastases
SHR-A1811, radiotherapy - Breast Cancer, Brain Metastases
Phase 1 / Phase 2Not yet recruitingPeking University Cancer Hospital & Institute512025-09-302025-09-17
LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study
Low-dose Radiotherapy, Pucotenlimab, AG regimen - Pancreatic Cancer, PD-L1
Phase 1 / Phase 2RecruitingZhejiang Provincial People's Hospital102025-09-302026-01-26
TAS-102 Plus Radiotherapy in Elderly ESCC
TAS-102, Radiotherapy - ESCC, TAS 102
Phase 1 / Phase 2Not yet recruitingQianfoshan Hospital452025-09-252025-09-29
Low Dose Radiotherapy for Heart Failure
Radiation Therapy - Heart Failure - NYHA II - IV
Phase 1 / Phase 2Not yet recruitingHospital do Coracao102025-07-142025-06-25
An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer
Nimotuzumab and Radiotherapy - Bladder (Urothelial, Transitional Cell) Cancer
Phase 1Not yet recruitingPeking University First Hospital302025-06-302025-07-08

Showing 20 of 639. Sign in to see all of them.

Conditions studied

Glioblastoma (90)  ·  Carcinoma, Non-Small-Cell Lung (78)  ·  Lung Neoplasms (62)  ·  Head and Neck Neoplasms (49)  ·  Squamous Cell Carcinoma of Head and Neck (42)  ·  Gliosarcoma (41)  ·  Central Nervous System Neoplasms (37)  ·  Pancreatic Neoplasms (33)  ·  Brain Neoplasms (31)  ·  Rectal Neoplasms (31)  ·  Sarcoma (28)  ·  Breast Neoplasms (26)  ·  Esophageal Neoplasms (26)  ·  Glioma (25)  ·  Lymphoma (24)

Sponsors

M.D. Anderson Cancer Center (53)  ·  National Cancer Institute (NCI) (47)  ·  Memorial Sloan Kettering Cancer Center (15)  ·  Radiation Therapy Oncology Group (15)  ·  Abramson Cancer Center at Penn Medicine (11)  ·  Fred Hutchinson Cancer Center (11)  ·  H. Lee Moffitt Cancer Center and Research Institute (11)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (11)  ·  Dana-Farber Cancer Institute (10)  ·  Northwestern University (10)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (9)  ·  Alliance for Clinical Trials in Oncology (8)  ·  Massachusetts General Hospital (8)  ·  Sichuan University (8)  ·  Children's Oncology Group (7)

Countries

United States (465)  ·  China (38)  ·  Canada (28)  ·  France (21)  ·  United Kingdom (19)  ·  Germany (17)  ·  Netherlands (17)  ·  Switzerland (16)  ·  Spain (15)  ·  Australia (13)  ·  Belgium (6)  ·  Italy (6)  ·  Norway (6)  ·  Sweden (5)  ·  Finland (4)

Top investigators

You Lu, MD (5)  ·  Peter W. Pisters, MD (4)  ·  Amol J. Ghia, MD (3)  ·  Arthur William Blackstock, MD (3)  ·  Corey J. Langer, MD (3)  ·  Deborah E Citrin, M.D. (3)  ·  Francisco Robert, MD, FACP (3)  ·  James L. Pearlman, MD (3)  ·  Anders Johnsson, MD, PhD (2)  ·  Anne S Tsao (2)  ·  Aude Chapuis (2)  ·  Bert H. O'Neil, MD (2)  ·  Brian Czito, MD (2)

Results publications

PMID 34780125, PMID 32827353, PMID 31500595, PMID 39863139, PMID 10501910, PMID 10797354, PMID 12171484, PMID 12631594, PMID 12885811, PMID 15117425, PMID 15246197, PMID 15328179, PMID 15667949, PMID 15863167, PMID 15890573, PMID 16116597, PMID 16170174, PMID 16198508, PMID 16391300, PMID 16421427, PMID 16520474, PMID 16730134, PMID 16855840, PMID 16889823, PMID 17084549, PMID 17278121, PMID 17308042, PMID 17336213, PMID 17410043, PMID 17482376, PMID 17560737, PMID 17869017, PMID 17896890, PMID 18299147, PMID 18394819, PMID 18418404, PMID 18565686, PMID 18723297, PMID 18845990, PMID 19010522, PMID 19060587, PMID 19096311, PMID 19100600, PMID 19179301, PMID 19509178, PMID 19525947, PMID 19533025, PMID 19536893, PMID 19540060, PMID 19596976

NIH funding

P30CA016672 (9), P30CA006973 (7), P30CA033572 (7), 2018 (5), U01CA062475 (5), U10CA180868 (5), P30CA006927 (4), P30CA043703 (4), P30CA060553 (4), P30CA068485 (4), 2016 (3), 2017 (3), 2023 (3), P30CA006516 (3), P30CA015704 (3)